{
    "Trade/Device Name(s)": [
        "FORA V10 No Code Blood Glucose Monitoring System, model TD-4244"
    ],
    "Submitter Information": "FORA Care Inc.",
    "510(k) Number": "K121706",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093035",
        "K093724"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "January 14, 2013",
    "Summary Letter Received Date": "January 7, 2013",
    "Submission Date": "May 18, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Single Analyte Control"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA V10 No Code Blood Glucose Monitoring System, model TD-4244"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for FORA V10 No Code Blood Glucose Monitoring System, model TD-4244 for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from various body sites for home monitoring of diabetes mellitus; not for diagnosis or use on neonates, intended for single patient use only.",
    "fda_folder": "Clinical Chemistry"
}